Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis

References

• Cao G, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019. JAMA Pediatr. 2022;176(8):787–796. doi: 10.1001/jamapediatrics.2022.1622.
   PubMed Web of Science ®Google Scholar
• Valenzuela CP, Gregory E, Martin JA. Mortality in the United States, 2016. NCHS Data Brief. 2022;429:1–8.
   Google Scholar
• McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985;312(2):82–90. doi: 10.1056/NEJM198501103120204.
   PubMed Web of Science ®Google Scholar
• United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & trends in child mortality: report 2017, estimates developed by the UN inter-agency group for child mortality estimation. New York: United Nations Children’s Fund; 2017.
   Google Scholar
• Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88(1):31–38. doi: 10.2471/BLT.08.062554.
   PubMed Web of Science ®Google Scholar
• Brown HK, Speechley KN, Macnab J, et al. Neonatal morbidity associated with late preterm and early term birth: the roles of gestational age and biological determinants of preterm birth. Int J Epidemiol. 2014;43(3):802–814. doi: 10.1093/ije/dyt251.
   PubMed Web of Science ®Google Scholar
• Kiefer DG, Vintzileos AM. The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth. Rev Obstet Gynecol. 2008;1(3):106–112.
   PubMedGoogle Scholar
• Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991;325(10):669–674. doi: 10.1056/NEJM199109053251001.
   PubMed Web of Science ®Google Scholar
• Leitich H, Egarter C, Kaider A, et al. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 1999;180(5):1169–1176. doi: 10.1016/s0002-9378(99)70612-5.
   PubMed Web of Science ®Google Scholar
• Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2016;215(4):431–438. doi: 10.1016/j.ajog.2016.04.038.
   PubMed Web of Science ®Google Scholar
• Abbott DS, Hezelgrave NL, Seed PT, et al. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk. Obstet Gynecol. 2015;125(5):1168–1176. Maydoi: 10.1097/AOG.0000000000000754.
   PubMed Web of Science ®Google Scholar
• Abbott DS, Radford SK, Seed PT, et al. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol. 2013;208(2):122. doi: 10.1016/j.ajog.2012.10.890.
   PubMed Web of Science ®Google Scholar
• Bruijn M, Van Baaren GJ, Vis J, et al. Does quantitative fetal fibronectin testing improve the prediction of spontaneous preterm delivery as compared to qualitative fetal fibronectin testing in symptomatic women: a post-hoc analysis. Am J Obstetrics Gynecology. 2014;210(1):S364. doi: 10.1016/j.ajog.2013.10.774.
   Web of Science ®Google Scholar
• Goepfert AR, Goldenberg RL, Mercer B, et al. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The national institute of child health and human development maternal-fetal medicine units network. Am J Obstet Gynecol. 2000;183(6):1480–1483. doi: 10.1067/mob.2000.107067.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Klebanoff M, Carey JC, et al. Vaginal fetal fibronectin measurements from 8 to 22 weeks’ gestation and subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000;183(2):469–475. doi: 10.1067/mob.2000.106073.
   PubMed Web of Science ®Google Scholar
• Kurtzman J, Chandiramani M, Briley A, et al. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery. Am J Obstet Gynecol. 2009;200(3):263 e1–6. doi: 10.1016/j.ajog.2009.01.018.
   PubMed Web of Science ®Google Scholar
• Ramsey P. Relationship of midtrimester fetal fibronectin (FFN) concentration to antibiotic efficacy for the prevention of spontaneous preterm birth in asymptomatic FFN positive women. Am J Obstet Gynecol. 2004;191(6):S11. doi: 10.1016/j.ajog.2004.09.059.
   PubMed Web of Science ®Google Scholar
• Vandermolen B, Hezelgrave NL, Seed P, et al. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women with previous cervical surgery. In: BJOG: an international journal of obstetrics and gynaecology. RCOG World Congress 2016; UK. 2016.
   Google Scholar
• Vandermolen BI, Hezelgrave NL, Smout EM, et al. Quantitative fetal fibronectin and cervical length to predict preterm birth in asymptomatic women with previous cervical surgery. Am J Obstet Gynecol. 2016;215(4):480.e1–480.e10.
   PubMed Web of Science ®Google Scholar
• Radford SK, Da Silva Costa F, Araujo JE, et al. Clinical application of quantitative foetal fibronectin for the prediction of preterm birth in symptomatic women. Gynecol Obstet Invest. 2018;83(3):285–289. doi: 10.1159/000480235.
   PubMed Web of Science ®Google Scholar
• Page MM, Bossuyt P, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71.
   Google Scholar
• Higgins JPT, Thomas J, Chandler J, et al. editors. Cochrane handbook for systematic reviews of interventions. version 6.1. Cochrane; 2020. (cited 2020 September). www.training.cochrane.org/handbook.
   Google Scholar
• Esplin MS, Elovitz MA, Iams JD, et al. Predictive accuracy of serial transvaginal cervical lengths and quantitative vaginal fetal fibronectin levels for spontaneous preterm birth among nulliparous women. JAMA. 2017;317(10):1047–1056. Mar 14doi: 10.1001/jama.2017.1373.
   PubMed Web of Science ®Google Scholar
• Jwala S, Tran TL, Terenna C, et al. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women. Acta Obstet Gynecol Scand. 2016;95(8):948–955. doi: 10.1111/aogs.12907.
   PubMed Web of Science ®Google Scholar
• Kurtzman J, Hezelgrave N, Abbott D, et al. 790: prediction of preterm birth in asymptomatic patients with twin gestations using a single quantitative fetal fibronectin screen. Am J Obstet Gynecol. 2014;210(1):S386–S387. doi: 10.1016/j.ajog.2013.10.823.
   Web of Science ®Google Scholar
• Norwitz E, Blackwell SC, Adair CD, et al. 545: quantitative fFN for prediction of spontaneous PTB in a high-risk asymptomatic population: the equate trial. Am J Obstet Gynecol. 2019;220(1):S365. doi: 10.1016/j.ajog.2018.11.567.
   Web of Science ®Google Scholar
• Tran TL, Jwala S, Terenna C, et al. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women. J Matern Fetal Neonatal Med. 2020;33(15):2628–2634. Aug
   PubMed Web of Science ®Google Scholar
• Muzaffar S, Behrens R, Barns F, et al. editors. Quantitative fetal fibronectin and preterm delivery: BJOG-an international journal of obstetrics and gynaecology. Hoboken: Wiley-Blackwell; 2013.
   Google Scholar
• Kurtzman J, Hezelgrave N, Abbott D, et al. 789: quantitative fetal fibronectin and cervical length screening at 22-27 6/7 weeks’ GA illuminate the spectrum of risk of preterm birth in asymptomatic twin gestations. Am J Obstet Gynecol. 2014;210(1):S386. doi: 10.1016/j.ajog.2013.10.822.
   Web of Science ®Google Scholar
• Hezelgrave N, Kurtzman J, Abbott D, et al. 10: quantitative fetal fibronectin assessment at 22 0/7-27 6/7 weeks’ GA significantly modifies the risk of preterm birth in asymptomatic high risk patients with sonographic cervical shortening. Am J Obstet Gynecol. 2015;212(1):S8–S9. doi: 10.1016/j.ajog.2014.10.056.
   Web of Science ®Google Scholar
• Hezelgrave NK, Cottam K, Seed PT, et al. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth. Eur J Obstet Gynecol Reprod Biol. 2017;208:103–108. doi: 10.1016/j.ejogrb.2016.11.027.
   PubMed Web of Science ®Google Scholar
• Kuhrt KH-EN, Stock SJ, Tribe R, et al. Quantitative fetal fibronectin for prediction of preterm birth in asymptomatic twin pregnancy. Acta Obstet Gynecol Scand. 2020;99(9):1191–1197. doi: 10.1111/aogs.13861.
   PubMed Web of Science ®Google Scholar
• Hezelgrave NL, Shennan AH. Quantitative fetal fibronectin to predict spontaneous preterm birth: a review. Womens Health. 2016;12(1):121–128. doi: 10.2217/whe.15.74.
   Web of Science ®Google Scholar
• Watson HA, Carlisle N, Kuhrt K, et al. EQUIPTT: the evaluation of the QUiPP app for triage and transfer protocol for a cluster randomised trial to evaluate the impact of the QUiPP app on inappropriate management for threatened preterm labour. BMC Pregnancy Childbirth. 2019;19(1):68. doi: 10.1186/s12884-019-2210-1.
   PubMedGoogle Scholar
• Danti L, Prefumo F, Lojacono A, et al. The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. J Matern Fetal Neonatal Med. 2011;24(10):1262–1266.
   PubMed Web of Science ®Google Scholar
• Ness A, Visintine J, Ricci E, et al. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol. 2007;197(4):426.e1–426.e7. doi: 10.1016/j.ajog.2007.07.017.
   PubMed Web of Science ®Google Scholar
• Nikolova T, Bayev O, Nikolova N, et al. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery. J Perinat Med. 2014;42(4):473–477. doi: 10.1515/jpm-2013-0234.
   PubMed Web of Science ®Google Scholar
• Paternoster D, Riboni F, Vitulo A, et al. Phosphorylated insulin-like growth factor binding protein-1 in cervical secretions and sonographic cervical length in the prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2009;34(4):437–440. doi: 10.1002/uog.6428.
   PubMed Web of Science ®Google Scholar
• Varley-Campbell JM-MR, Coelho H, Ocean N, et al. Biomarker tests to help diagnose preterm labour in women with intact membranes. Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School (Report for NICE). 2018.
   Google Scholar